NCT06833216

Familial Breast Cancer in China

A Real-world Study of Familial Hereditary Breast Cancer in China

• Status: Not Yet Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 500 (estimated)
• Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences · Academic / Other
• Sex: Female
• Age: 18 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

This study is a retrospective descriptive study to collect clinical data (mainly including medical records and follow-up information, etc.) of breast cancer patients with genetic variation who were first diagnosed and treated in a number of hospitals in China during the period from January 1, 2015 to December 31, 2024, and to establish a retrospective cohort of familial hereditary breast cancer. To analyze the clinical features, diagnosis and treatment and survival prognosis of patients with familial hereditary breast cancer. To explore the main factors affecting clinical diagnosis and treatment and survival prognosis of patients

Conditions

• Breast Carcinoma
• Genetic Variation

Interventions

Type	Name	Description
OTHER	Genetic variation	To observe and describe the clinical features, diagnosis and treatment plan and survival prognosis of familial hereditary breast cancer in China, and explore the main factors affecting prognosis.

Timeline

• Start date: 2025-02-28
• Primary completion: 2025-02-28
• Completion: 2035-02-28
• First posted: 2025-02-18
• Last updated: 2025-02-18

Locations

1 site across 1 country: China